Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Eli Lilly and Company (LLY) had Consolidated Net Income/Loss of $2.24B for the most recently reported fiscal quarter, ending 2024-03-31.
Income Statement Financials | |
$8.77B |
|
$2.24B |
|
$1.67B |
|
$7.09B |
|
$6.26B |
|
$2.51B |
|
$27.10M |
|
$2.54B |
|
$2.54B |
|
$2.24B |
|
$2.24B |
|
Consolidated Net Income/Loss |
$2.24B |
$2.24B |
|
$2.51B |
|
$2.91B |
|
900.80M |
|
903.80M |
|
$2.49 |
|
$2.48 |
|
Balance Sheet Financials | |
$25.19B |
|
$13.62B |
|
$38.75B |
|
$63.94B |
|
$18.60B |
|
$24.56B |
|
$32.45B |
|
$51.05B |
|
$12.90B |
|
$1.20B |
|
$12.90B |
|
950.40M |
|
Cash Flow Statement Financials | |
$1.17B |
|
$-1.18B |
|
$-311.30M |
|
$2.82B |
|
$2.46B |
|
$-358.40M |
|
$159.40M |
|
$-1.17B |
|
-- |
|
Fundamental Metrics & Ratios | |
1.35 |
|
-- |
|
-- |
|
0.66 |
|
2.03 |
|
80.91% |
|
28.62% |
|
28.62% |
|
-- |
|
28.92% |
|
25.58% |
|
$179.70M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.27 |
|
0.88 |
|
102.78 |
|
17.39% |
|
187.60% |
|
3.51% |
|
5.99% |
|
$13.57 |
|
$0.20 |
|
$1.29 |